6DLZ_A_CYZA1302 |
6dlz |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattusnorvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) |
10 |
ILE D 481PRO A 494MET A 496SER A 497SER D 729GLY D 731LEU A 751SER A 754ASP A 760LYS A 763 |
CYZ A1302
| |
6DLZ_B_CYZB1302 |
6dlz |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattusnorvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE C 481PRO C 494MET B 496SER B 497SER C 729LEU B 751SER B 754LEU B 759ASP B 760LYS B 763 |
CYZ B1302
| |
6DLZ_C_CYZC1302 |
6dlz |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattusnorvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE B 481PRO C 494MET C 496SER C 497SER B 729GLY B 731LEU C 751SER C 754ASP C 760LYS C 763 |
CYZ C1302
| |
6DLZ_D_CYZD1302 |
6dlz |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattusnorvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) |
11 |
ILE A 481PRO A 494PRO D 494MET D 496SER D 497SER A 729LEU D 751SER D 754LEU D 759ASP D 760LYS D 763 |
CYZ D1302
| |
6DM0_A_CYZA1302 |
6dm0 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattusnorvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan-Glu_bd)PF01094(Lig_chan)PF10613(ANF_receptor) |
9 |
ILE D 481PRO A 494MET A 496SER A 497SER D 729LEU A 751SER A 754ASP A 760LYS A 763 |
CYZ A1302
| |
6DM0_B_CYZB1302 |
6dm0 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattusnorvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE C 481PRO C 494MET B 496SER B 497SER C 729GLY C 731LEU B 751LEU B 759ASP B 760LYS B 763 |
CYZ B1302
| |
6DM0_C_CYZC1302 |
6dm0 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattusnorvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
9 |
ILE B 481PRO C 494MET C 496SER C 497SER B 729LEU C 751SER C 754ASP C 760LYS C 763 |
CYZ C1302
| |
6DM0_D_CYZD1302 |
6dm0 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattusnorvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan-Glu_bd)PF01094(Lig_chan)PF10613(ANF_receptor) |
9 |
PRO A 494MET D 496SER D 497SER A 729GLY A 731LEU D 751LEU D 759ASP D 760LYS D 763 |
CYZ D1302
| |
6DM1_A_CYZA1302 |
6dm1 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattusnorvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(ANF_receptor)PF00822(Lig_chan)PF01094(Lig_chan-Glu_bd)PF10613(PMP22_Claudin) |
10 |
ILE D 481PRO A 494MET A 496SER A 497SER D 729GLY D 731LEU A 751SER A 754ASP A 760LYS A 763 |
CYZ A1302
| |
6DM1_B_CYZB1302 |
6dm1 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattusnorvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE C 481PRO C 494MET B 496SER B 497SER C 729LEU B 751SER B 754LEU B 759ASP B 760LYS B 763 |
CYZ B1302
| |
6DM1_C_CYZC1302 |
6dm1 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattusnorvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE B 481PRO C 494MET C 496SER C 497SER B 729GLY B 731LEU C 751SER C 754ASP C 760LYS C 763 |
CYZ C1302
| |
6DM1_D_CYZD1302 |
6dm1 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattusnorvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(ANF_receptor)PF00822(Lig_chan)PF01094(Lig_chan-Glu_bd)PF10613(PMP22_Claudin) |
11 |
ILE A 481PRO A 494PRO D 494MET D 496SER D 497SER A 729LEU D 751SER D 754LEU D 759ASP D 760LYS D 763 |
CYZ D1302
| |
6DM2_A_CYZA1302 |
6dm2 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattusnorvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) |
9 |
ILE D 481PRO A 494MET A 496SER A 497SER D 729LEU A 751SER A 754ASP A 760LYS A 763 |
CYZ A1302
| |
6DM2_B_CYZB1302 |
6dm2 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattusnorvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE C 481PRO C 494MET B 496SER B 497SER C 729LEU B 751SER B 754LEU B 759ASP B 760LYS B 763 |
CYZ B1302
| |
6DM2_C_CYZC1302 |
6dm2 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattusnorvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
9 |
ILE B 481PRO C 494MET C 496SER C 497SER B 729LEU C 751SER C 754ASP C 760LYS C 763 |
CYZ C1302
| |
6DM2_D_CYZD1302 |
6dm2 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattusnorvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) |
10 |
ILE A 481PRO A 494MET D 496SER D 497SER A 729LEU D 751SER D 754LEU D 759ASP D 760LYS D 763 |
CYZ D1302
| |